Back to Search
Start Over
Burden of basal cell carcinoma in USA
- Source :
- Future Oncology. 11:2967-2974
- Publication Year :
- 2015
- Publisher :
- Future Medicine Ltd, 2015.
-
Abstract
- Basal cell carcinoma (BCC) is the most common malignancy diagnosed in the USA and its incidence continues to increase. While BCC is still most prevalent in the older segments of the population, it is becoming ever more frequent in younger individuals. The costs of treatment and morbidity associated with BCCs place a heavy public health and economic burden on patients, their families and the American healthcare system and underscore the importance of efficient management and prevention efforts directed toward this malignancy. In this article, we address economic aspects of BCC using evidence from large-scale epidemiological studies. This information may help clinicians in developing better and more cost-effective methods for dealing with the most common cancer in America and in the world.
- Subjects :
- Cancer Research
medicine.medical_specialty
Skin Neoplasms
Cost effectiveness
Cost-Benefit Analysis
Population
Malignancy
Epidemiology
Health care
medicine
Humans
Basal cell carcinoma
Intensive care medicine
education
education.field_of_study
business.industry
Incidence
Public health
Health Care Costs
General Medicine
medicine.disease
United States
Surgery
Oncology
Carcinoma, Basal Cell
Skin cancer
business
Subjects
Details
- ISSN :
- 17448301 and 14796694
- Volume :
- 11
- Database :
- OpenAIRE
- Journal :
- Future Oncology
- Accession number :
- edsair.doi.dedup.....c22f85c9d453dfa9b22109c6072cb00b